COMI, Cristoforo
 Distribuzione geografica
Continente #
EU - Europa 9.619
NA - Nord America 6.733
AS - Asia 5.292
SA - Sud America 920
AF - Africa 192
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 3
Totale 22.770
Nazione #
US - Stati Uniti d'America 6.530
RU - Federazione Russa 2.231
NL - Olanda 1.908
SG - Singapore 1.859
IE - Irlanda 1.492
CN - Cina 1.215
IT - Italia 879
DE - Germania 863
VN - Vietnam 738
HK - Hong Kong 701
BR - Brasile 696
SE - Svezia 622
UA - Ucraina 494
FR - Francia 354
FI - Finlandia 304
IN - India 192
GB - Regno Unito 175
CA - Canada 120
BD - Bangladesh 110
KR - Corea 95
AR - Argentina 87
BJ - Benin 78
ID - Indonesia 77
JP - Giappone 63
PL - Polonia 61
MX - Messico 57
EC - Ecuador 47
ZA - Sudafrica 44
CZ - Repubblica Ceca 43
AT - Austria 38
ES - Italia 34
TR - Turchia 33
IR - Iran 30
IQ - Iraq 29
BE - Belgio 28
CO - Colombia 23
LT - Lituania 23
GR - Grecia 21
PY - Paraguay 21
MA - Marocco 17
SA - Arabia Saudita 17
PH - Filippine 14
PK - Pakistan 14
CL - Cile 13
UZ - Uzbekistan 13
EG - Egitto 12
IL - Israele 12
VE - Venezuela 12
DZ - Algeria 11
PE - Perù 11
AE - Emirati Arabi Uniti 9
EU - Europa 9
RO - Romania 9
AZ - Azerbaigian 8
KE - Kenya 8
NP - Nepal 8
KZ - Kazakistan 7
TW - Taiwan 7
UY - Uruguay 7
CH - Svizzera 6
LB - Libano 6
TN - Tunisia 6
AL - Albania 5
JM - Giamaica 5
JO - Giordania 5
KW - Kuwait 5
LV - Lettonia 5
MD - Moldavia 5
MY - Malesia 5
SN - Senegal 5
TH - Thailandia 5
BG - Bulgaria 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
PA - Panama 4
AU - Australia 3
DK - Danimarca 3
OM - Oman 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
GA - Gabon 2
HN - Honduras 2
LK - Sri Lanka 2
PT - Portogallo 2
QA - Qatar 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
DM - Dominica 1
EE - Estonia 1
GD - Grenada 1
GM - Gambi 1
IS - Islanda 1
Totale 22.755
Città #
Amsterdam 1.891
Dublin 1.490
San Jose 915
Jacksonville 860
Hong Kong 694
Singapore 642
Ashburn 445
Dearborn 431
Beijing 338
Moscow 282
Los Angeles 252
Ho Chi Minh City 232
Chandler 213
Lauterbourg 213
Wilmington 199
Lawrence 179
Princeton 179
Council Bluffs 146
Hanoi 138
New York 126
San Mateo 110
Milan 106
Buffalo 105
Ann Arbor 98
Munich 96
Piemonte 89
Seoul 86
Dallas 84
Cotonou 78
São Paulo 74
Andover 72
Helsinki 72
Santa Clara 70
Boardman 68
Orem 68
Novara 67
Turin 62
Rome 54
Dong Ket 52
Warsaw 47
Bremen 45
Chennai 44
Denver 43
Tokyo 43
Houston 40
Toronto 40
Falkenstein 39
Brno 38
Frankfurt am Main 37
Nuremberg 37
Redondo Beach 37
Jakarta 36
Da Nang 34
Monmouth Junction 34
Woodbridge 34
Guangzhou 33
Chicago 32
Hefei 31
Johannesburg 31
Brooklyn 30
Hangzhou 30
Tianjin 30
Grafing 29
London 29
Montreal 29
St Louis 28
Manchester 27
Poplar 27
Turku 27
Brussels 26
Mumbai 26
Stockholm 26
Torino 26
Atlanta 25
Phoenix 25
Strasbourg 25
Boston 24
Haiphong 24
Nanjing 24
Seattle 24
Düsseldorf 22
Guayaquil 21
Mexico City 21
Rio de Janeiro 19
Vienna 19
Belo Horizonte 18
Mülheim 18
Ankara 17
Norwalk 17
Vercelli 17
Dhaka 15
Fairfield 15
Hải Dương 15
Kunming 15
Shanghai 15
Alessandria 14
Biên Hòa 14
Porto Alegre 14
Jinan 13
Quito 13
Totale 13.024
Nome #
Post-lumbar puncture headache: an adverse effect in multiple sclerosis work-up 1.917
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 256
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 199
Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report 176
Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis-A real-world evidence study 173
Change over time of COVID-19 hospital presentation in Northern Italy 165
Anti-cytokine autoantibodies in autoimmune diseases 154
Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson's disease 148
Impaired visual inhibition in migraine with aura. 147
Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis 146
Cortical visuomotor interactions in Freezing of Gait: A TMS approach 144
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 143
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis 143
Circulating extracellular vesicles in subarachnoid hemorrhage patients: characterization and cellular effects 141
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 138
Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis 137
Insights into the protective role of immunity in neurodegenerative disease 135
Kappa free light chains could predict early disease course in multiple sclerosis 133
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 133
Calcium and glutamate involvement in activation of multiple sclerosis patient lymphocytes 131
Combined use of Kappa Free Light Chain Index and Isoelectrofocusing of Cerebro-Spinal Fluid in Diagnosing Multiple Sclerosis: Performances and Costs 130
A91V variation of the perforin gene in patients with multiple sclerosis 129
Abnormal response to glutamate of T lymphocytes from multiple sclerosis patients 128
Phenotypic heterogeneity of movement disorders due to intracranial calcifications with or without SLC20A2 mutations 128
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 128
Cerebrospinal fluid levels of tissue inhibitor of metalloproteinase 1 are increased in subjects with mild cognitive impairment 127
Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases 125
A patient with autoimmune limb-girdle myasthenia, and a brief review of this treatable condition 125
K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up 125
Polymorphisms of dopamine receptor genes and parkinson’s disease: Clinical relevance and future perspectives 125
Exploring serum and CSF Calcitonin Gene Related Peptide levels: A promising biomarker in multiple sclerosis? 124
Chronic obstructive pulmonary disease may complicate Alzheimer's disease: a comorbidity problem 124
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis 124
A case of progressive multifocal leukoencephalopathy after autologous bone marrow transplantation successfully treated with mirtazapine and cidofovir 120
An investigation of the role of common and rare variants in a large italian multiplex family of multiple sclerosis patients 120
Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental Population 119
Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo 118
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 117
Advances in Neuroimmunology: From Bench to Bedside 116
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 116
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 115
Polymorphisms of dopamine receptor genes and risk of l-dopa–induced dyskinesia in parkinson’s disease 115
Short-term videoEEG: Review of a 3-year experience [Short-term videoEEG: Studio retrospettivo di 3 anni di esperienza clinica] 114
Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis 114
MOG-antibody demyelinating diseases: a case of post-partum severe rhombencephalitis and transverse myelitis 113
Nerve conduction, circulating osteopontin and taxane-induced neuropathy in breast cancer patients 113
Kappa index for multiple sclerosis diagnosis: an accurate biomarker of intrathecal synthesis 112
Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence 112
ICOS gene haplotypes correlate with multiple sclerosis development and progression 111
Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP 111
Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know? 111
Complex pattern of convulsive syncope in glossopharyngeal neuralgia: video/EEG report and short review 110
Beta2-Adrenoceptor Agonists in Parkinson’s Disease and Other Synucleinopathies 110
The length of SNCA Rep1 microsatellite may influence cognitive evolution in Parkinson’s disease 109
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 108
Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy 108
Prognostic Role of Visual Evoked Potentials in Non-Neuritic Eyes at Multiple Sclerosis Diagnosis 107
Intrathecal kappa free light chains as markers for multiple sclerosis 107
The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function 107
Cerebrospinal Fluid Biomarkers in Progranulin Mutations Carriers 104
Erratum: Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (Cell (2019) 178(1) (262), (S0092867419306798), (10.1016/j.cell.2019.06.016)) 104
The Yin-Yang of osteopontin in nervous system diseases: Damage versus repair 104
A novel genetic prediction score in myoclonus-dystonia 102
IV lacosamide: Report of two cases of successful treatment of refractory status epilepticus [Utilizzo di lacosamide ev: Esperienza in due casi di stato di male epilettico refrattario] 102
A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy 101
Osteopontin is increased in the cerebrospinal fluid of patients with early Alzheimer's disease and its levels correlate with cognitive deterioration 101
The spectrum of movement disorders in chronic liver disease: A cross-sectional study 101
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study 101
Early Predictors of Disability and Cognition in Multiple Sclerosis Patients: A Long-Term Retrospective Analysis 100
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 100
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk 100
Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple Sclerosis 100
CD4+ T-Cell Transcription Factors in Idiopathic REM Sleep Behavior Disorder and Parkinson’s Disease 99
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 98
Longitudinal Assessment of Transorbital Sonography, Visual Acuity, and Biomarkers for Inflammation and Axonal Injury in Optic Neuritis 98
Intensive Rehabilitation Treatment in Early Parkinson's Disease: A Randomized Pilot Study With a 2-Year Follow-up 98
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 98
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 97
Paraneoplastic neuromyelitis optica spectrum disorders: a case series 96
Serum vitamin d as a marker of impaired information processing speed and early disability in multiple sclerosis patients 96
Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline 95
Holmes tremor caused by a natalizumab-related progressive multifocal leukoencephalopathy: a case report and brief review of the literature 95
Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio Are Associated with Mild Cognitive Impairment in Parkinson's Disease: A Single-Center Longitudinal Study 94
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 94
Variations of the perforin gene in patients with multiple sclerosis 94
LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients 94
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: Cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients 94
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression 94
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression 94
Anticonvulsant Drugs and Cognitive Functions in Elderly Patients with Epilepsy 93
Robotic gait training is not superior to conventional treadmill training in Parkinson's Disease: A single-blind randomized controlled trial 93
Transorbital Sonography and Visual Outcome for the Diagnosis and Monitoring of Optic Neuritis 93
Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis 93
Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: A retrospective case-control study 93
A very early onset of juvenile parkinsonism 92
Immunity and inflammation in neurodegenerative diseases. 92
T Lymphocytes in Parkinson's Disease 92
Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome. 91
Effectiveness of Intensive Inpatient Rehabilitation Treatment on Disease Progression in Parkinsonian Patients: A Randomized Controlled Trial With 1-Year Follow-up 91
Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens. 90
Totale 13.395
Categoria #
all - tutte 109.400
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.400


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 0 0 0 0 0 0 60
2021/20221.232 69 36 130 137 57 18 127 22 120 47 176 293
2022/20232.596 204 138 135 27 118 183 85 101 1.439 18 98 50
2023/20241.201 77 52 114 48 202 23 210 70 27 13 108 257
2024/20252.939 65 47 200 96 63 217 288 213 740 207 249 554
2025/202611.689 438 338 675 1.475 981 653 1.521 1.667 2.459 776 606 100
Totale 23.081